| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Hr Officer | Sell | 427 | $115.05 | $49,126.95 | -0.6% | -40.2% | -27.2% | |
| Jun 10, 2024 | MXCT Maxcyte, Inc. | Masoud Maher54 | President And CEO | Buy | 100,000 | $4.89 | $489,065.51 | +338.3% | -22.8% | -53.4% | |
| Jun 10, 2024 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 175,616 | $16.69 | $2,930,499.40 | -87.7% | -17.5% | +31.5% | |
| Jun 7, 2024 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 76,582 | $16.65 | $1,275,121.94 | -75.9% | -18.6% | +29.8% | |
| Jun 7, 2024 | RMD Resmed Inc | Farrell Michael J.63 | Chief Executive Officer | Sell | 14,683 | $211.66 | $3,107,739.17 | -3.2% | +16.1% | +19.6% | |
| Jun 7, 2024 | MDT Medtronic Plc | Martha Geoffrey52 | Chairman And CEO | Sell | 19,113 | $83.77 | $1,601,000.52 | -6.2% | +6.3% | +4.0% | |
| Jun 7, 2024 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 85,148 | $16.63 | $1,416,047.67 | -14.2% | -18.6% | +29.8% | |
| Jun 6, 2024 | INCY Incyte Corp | Tray Thomas55 | Principal Accounting Officer | Sell | 1,093 | $58.91 | $64,388.63 | -4.8% | +10.1% | +17.7% | |
| Jun 6, 2024 | STIM Neuronetics, Inc. | Cascella Robert63 | Director | Buy | 50,000 | $2.05 | $102,550.00 | +25.8% | -59.5% | +83.3% | |
| Jun 6, 2024 | NMTC Neuroone Medical Technologies Corp | Christianson Mark67 | Business Development Director | Sell | 2,189 | $0.88 | $1,917.56 | -0.7% | -11.6% | -31.5% | |
| Jun 6, 2024 | HBIO Harvard Bioscience Inc | Green James W70 | Chief Executive Officer | Buy | 20,000 | $3.07 | $61,400.00 | +0.6% | -7.7% | -86.3% | |
| Jun 6, 2024 | ATR Aptargroup, Inc. | Chainey Kimberly49 | EVP And Chief Legal Officer | Sell | 825 | $146.77 | $121,085.83 | -8.6% | +3.3% | +5.0% | |
| Jun 5, 2024 | TMDX Transmedics Group, Inc. | Basile Edward M64 | Director | Sell | 1,193 | $138.08 | $164,729.44 | -62.0% | +18.0% | +0.4% | |
| Jun 5, 2024 | ISRG Intuitive Surgical Inc | Barratt Craig H48 | Director | Sell | 1,400 | $411.00 | $575,400.00 | -100% | +15.9% | +33.8% | |
| Jun 5, 2024 | STE Steris Plc | Madsen Julia | Senior VP, Life Sciences | Sell | 3,652 | $230.00 | $839,960.00 | -15.9% | +5.8% | +5.9% | |
| Jun 5, 2024 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Chief Executive Officer | Buy | 38,505 | $6.43 | $247,587.15 | +18.2% | -6.9% | -19.2% | |
| Jun 5, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 11,754 | $0.90 | $10,602.11 | -0.8% | +24.4% | +145.7% | |
| Jun 5, 2024 | STE Steris Plc | Majors Cary L54 | SVP And President, Healthcare | Sell | 4,932 | $229.63 | $1,132,535.16 | -27.4% | +5.8% | +5.9% | |
| Jun 5, 2024 | NMTC Neuroone Medical Technologies Corp | Christianson Mark67 | Business Development Director | Sell | 25,800 | $0.88 | $22,662.72 | -8.0% | -9.4% | -32.2% | |
| Jun 4, 2024 | NVCR Novocure Ltd | Vernon W Anthony | Director | Sell | 964 | $23.89 | $23,032.85 | -0.6% | -26.6% | -26.7% | |
| Jun 4, 2024 | RDGL Vivos Inc | Korenko Michael K | CEO And President | Buy | 50,000 | $0.17 | $8,435.00 | +0.5% | - | - | |
| Jun 4, 2024 | NVCR Novocure Ltd | Leung Gabriel78 | Director | Sell | 964 | $23.89 | $23,025.24 | -1.2% | -26.6% | -26.7% | |
| Jun 4, 2024 | PODD Insulet Corp | Borio Luciana46 | Director | Sell | 360 | $182.58 | $65,728.80 | -9.8% | +13.7% | +75.6% | |
| Jun 4, 2024 | ITGR Integer Holdings Corp | Harris John A45 | EVP, Global Ops And Manufactur | Sell | 1,521 | $120.44 | $183,181.64 | -23.6% | +6.3% | +0.7% | |
| Jun 4, 2024 | NVCR Novocure Ltd | Scannell Timothy J | Director | Sell | 964 | $23.89 | $23,027.45 | -24.5% | -26.6% | -26.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.